Literature DB >> 12837408

Urodynamic effects of alpha-adrenoceptor blockers: a review of clinical trials.

Barbara B M Kortmann1, Diamandis L Floratos, Lambertus A L M Kiemeney, Hessel Wijkstra, Jean J M C H de la Rosette.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12837408     DOI： 10.1016/s0090-4295(02)02113-1

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  17 in total

1.  [S2e guideline of the German urologists: Conservative and pharmacologic treatment of benign prostatic hyperplasia].

Authors:  K Höfner; T Bach; R Berges; K Dreikorn; C Gratzke; S Madersbacher; M-S Michel; R Muschter; M Oelke; O Reich; C Tschuschke; T Bschleipfer
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

2.  [Therapy of benign prostate syndrome (BPS): guidelines of the German Urologists (DGU)].

Authors:  R Berges; K Dreikorn; K Höfner; S Madersbacher; M C Michel; R Muschter; M Oelke; O Reich; W Rulf; C Tschuschke; U Tunn
Journal:  Urologe A       Date:  2009-12       Impact factor: 0.639

Review 3.  [Importance of adrenoceptor blockers and alpha reductase inhibitors : Monotherapy for treatment of benign prostate syndrome].

Authors:  F Strittmatter; S Madersbacher; C G Stief; C Gratzke
Journal:  Urologe A       Date:  2013-02       Impact factor: 0.639

4.  Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3.

Authors:  Qingfeng Yu; Christian Gratzke; Yiming Wang; Annika Herlemann; Christian Maximilian Sterr; Beata Rutz; Anna Ciotkowska; Xiaolong Wang; Frank Strittmatter; Christian G Stief; Martin Hennenberg
Journal:  Br J Pharmacol       Date:  2018-04-29       Impact factor: 8.739

5.  [Medical therapy of lower urinary tract symptoms [corrected]].

Authors:  F Strittmatter; S Madersbacher; C G Stief; C Gratzke
Journal:  Urologe A       Date:  2012-08       Impact factor: 0.639

Review 6.  Emerging treatment options for benign prostatic obstruction.

Authors:  Brian A Parsons; Hashim Hashim
Journal:  Curr Urol Rep       Date:  2011-08       Impact factor: 3.092

Review 7.  Cataract surgery in patients taking alpha-1 antagonists: know the risks, avoid the complications.

Authors:  Daniel M Handzel; Sebastian Briesen; Steffen Rausch; Tilman Kälble
Journal:  Dtsch Arztebl Int       Date:  2012-05-25       Impact factor: 5.594

Review 8.  [Treatment of LUTS in BPS. When and when not to administer pills?].

Authors:  R Berges
Journal:  Urologe A       Date:  2009-03       Impact factor: 0.639

Review 9.  Does anticholinergic medication have a role in treating men with overactive bladder and benign prostatic hyperplasia?

Authors:  Kyu-Sung Lee; Hye Won Lee; Deok Hyun Han
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-01-03       Impact factor: 3.000

Review 10.  Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.

Authors:  Martin C Michel; Wim Vrydag
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.